Pharmacologic increases in erythrocyte 2,3-diphosphoglycerate for therapeutic benefit.
D000818:Animals; D001769:Blood; D001793:Blood Preservation; D001803:Blood Transfusion; D002302:Cardiac Output / Q000187:drug effects; D002951:Citrates; D004163:Diphosphoglyceric Acids / Q000008:administration & dosage / Q000097:blood* / Q000494:pharmacology / Q000627:therapeutic use; D004357:Drug Synergism; D004912:Erythrocytes / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D005078:Exchange Transfusion, Whole Blood; D005947:Glucose; D000882:Haplorhini; D006863:Hydrogen-Ion Concentration; D000860:Hypoxia / Q000188:drug therapy*; D007263:Infusions, Parenteral; D007288:Inosine / Q000008:administration & dosage / Q000494:pharmacology; D010100:Oxygen / Q000097:blood; D010215:Papio; D010710:Phosphates / Q000008:administration & dosage / Q000494:pharmacology; D011773:Pyruvates / Q000008:administration & dosage / Q000494:pharmacology; D011817:Rabbits
D002951:Citrates; D004163:Diphosphoglyceric Acids; D010710:Phosphates; D011773:Pyruvates; D007288:Inosine; D005947:Glucose; D010100:Oxygen